Cargando…

Molecule of the month: miRNA and Huntington's disease (HD)

Detalles Bibliográficos
Autor principal:	Shapshak, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717180/ https://www.ncbi.nlm.nih.gov/pubmed/23888093 http://dx.doi.org/10.6026/97320630009549

Ejemplares similares

Molecule of the month: miRNA and proteins in Alzheimer's disease
por: Shapshak, Paul
Publicado: (2013)

Molecule of the month: miRNA and Down's syndrome
por: Shapshak, Paul
Publicado: (2013)

Molecule of the month: miRNA and Multiple Sclerosis
por: Shapshak, Paul
Publicado: (2013)

Molecule of the month: miRNA and Human Prion brain disease
por: Shapshak, Paul
Publicado: (2013)

Molecule of the month: miRNA and HIV-1 TAR
por: Shapshak, Paul
Publicado: (2013)

Molecule of the month HIV-1 Tat and miRNA
por: Shapshak, Paul
Publicado: (2012)

Molecule of the month: miRNA and Parkinson's disease protein PARK2
por: Shapshak, Paul
Publicado: (2013)

Molecule of the month: Synaptic plasticity – Protein miRNA interactions
por: Shapshak, Paul
Publicado: (2012)

Molecule of the month: HIV-1 protein Vpr and miRNA
por: Shapshak, Paul
Publicado: (2012)

Molecule of the month: miRNA and proteins DARPP-32, DRD1, SLC6A3, and CK2
por: Shapshak, Paul
Publicado: (2013)

Dementia and molecule of the month APP
por: Shapshak, Paul
Publicado: (2012)

NRF2 molecule of the month
por: Shapshak, Paul
Publicado: (2012)

Molecule of the month, PDE4DIP
por: Shapshak, Paul
Publicado: (2012)

Bioinformation and molecule of the month: Multiple interactive pathways for a single gene, NFkB
por: Shapshak, Paul
Publicado: (2012)

Disease Burden of Huntington’s Disease (HD) on People Living with HD and Care Partners in Canada
por: Shaw, Eileen, et al.
Publicado: (2022)

Single nucleotide polymorphisms (SNPs) for genome wide association studies (GWAS) and molecule of the month Nitric Oxide Synthase, multiple interactive pathways for three similar genes, Nitric Oxide Synthase-1, -2, -3 (NOS-1, -2, -3)
por: Shapshak, Paul
Publicado: (2012)

Refining the diagnosis of Huntington disease: the PREDICT-HD study
por: Biglan, Kevin M., et al.
Publicado: (2013)

Deciphering miRNA–Target Relationships to Understand miRNA-Mediated Carcinogenesis
por: Navarro, Alfons
Publicado: (2021)

Multi-Modal Neuroimaging in Premanifest and Early Huntington’s Disease: 18 Month Longitudinal Data from the IMAGE-HD Study
por: Domínguez D, Juan F., et al.
Publicado: (2013)

Discovery of a potent small molecule inhibiting Huntington’s disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein
por: Khan, Eshan, et al.
Publicado: (2019)

Detection of Huntington’s disease decades before diagnosis: the Predict-HD study
por: Paulsen, J S, et al.
Publicado: (2008)

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
por: Klöppel, Stefan, et al.
Publicado: (2015)

Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?
por: Tucci, Paolo, et al.
Publicado: (2022)

Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
por: Ogilvie, Amy C., et al.
Publicado: (2023)

Prevalence of neurocognitive disorder in Huntington’s disease using the Enroll-HD dataset
por: Sierra, Luis A., et al.
Publicado: (2023)

Potential role of miRNA-140 in Alzheimer’s disease
por: Akhter, Rumana, et al.
Publicado: (2019)

Dysregulated miRNA and mRNA Expression Affect Overlapping Pathways in a Huntington’s Disease Model
por: Zsindely, Nóra, et al.
Publicado: (2023)

Insight into miRNA biogenesis with RNA sequencing
por: Conrad, Thomas, et al.
Publicado: (2015)

Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT‐HD
por: Long, Jeffrey D., et al.
Publicado: (2015)

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study
por: Reed, Eric R., et al.
Publicado: (2018)

Exploring the predictors of financial impairment in Huntington’s disease using the Enroll-HD dataset
por: Harris, Kate L., et al.
Publicado: (2022)

Digesting dietary miRNA therapeutics
por: Yarmarkovich, Mark, et al.
Publicado: (2015)

Stem Cells for Huntington’s Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington’s Disease
Publicado: (2021)

Coronavirus disease 2019 and mRNA vaccines: what’s next – miRNA?
por: Lee, Joon Kee, et al.
Publicado: (2022)

Decreased Striatal RGS2 Expression Is Neuroprotective in Huntington's Disease (HD) and Exemplifies a Compensatory Aspect of HD-Induced Gene Regulation
por: Seredenina, Tamara, et al.
Publicado: (2011)

Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells
por: Meng, Lingyu, et al.
Publicado: (2017)

The role of miRNA molecules in the miscarriage process
por: Omeljaniuk, Wioleta Justyna, et al.
Publicado: (2023)

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
por: Frank, Samuel
Publicado: (2009)

Volumetric Analysis of the Hypothalamus in Huntington Disease Using 3T MRI: The IMAGE-HD Study
por: Gabery, Sanaz, et al.
Publicado: (2015)

Accuracy of automated amygdala MRI segmentation approaches in Huntington's disease in the IMAGE‐HD cohort
por: Alexander, Bonnie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q2e6qm7scqlu357ijq3qa8b93b